Margaret von Mehren Selected Research

Margaret von Mehren Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 08/2002
57	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 08/2002
27	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2005
16	Disease Progression 11/2021 - 08/2008
13	Liposarcoma 01/2022 - 08/2005
9	Leiomyosarcoma 12/2019 - 12/2003
8	Fatigue 01/2022 - 08/2002
5	Nausea 01/2022 - 09/2009
4	Carcinogenesis 08/2017 - 05/2005
3	Anemia 11/2021 - 09/2009
3	Hypertension (High Blood Pressure) 01/2020 - 10/2012
3	Thrombocytopenia (Thrombopenia) 01/2017 - 10/2008
3	Neutropenia 05/2015 - 10/2008
3	Melanoma (Melanoma, Malignant) 09/2014 - 07/2010
3	Tetanus 07/2011 - 08/2008
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2011 - 08/2002
2	Synovial Sarcoma (Synovioma) 01/2022 - 11/2015
2	Myxoid Liposarcoma 01/2022 - 10/2016
2	Abdominal Pain (Pain, Abdominal) 11/2021 - 03/2009
2	Hemangiosarcoma (Angiosarcoma) 09/2021 - 11/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 05/2008
2	Aggressive Fibromatosis (Desmoid) 12/2020 - 08/2012
2	Diarrhea 10/2020 - 08/2002
2	Myalgia 10/2020 - 04/2007
2	Alopecia (Baldness) 10/2020 - 09/2009
2	Febrile Neutropenia 05/2015 - 11/2009
2	Leukemia 06/2013 - 11/2008
2	Fever (Fevers) 09/2009 - 04/2007
2	Colorectal Neoplasms (Colorectal Cancer) 08/2008 - 02/2005
1	Pneumonia (Pneumonitis) 01/2022
1	Pulmonary Embolism 01/2022
1	Extraskeletal Myxoid Chondrosarcoma 10/2021
1	Microsatellite Instability 09/2021
1	Constipation 10/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Dehydration (Water Stress) 01/2020

Drug/Important Bio-Agent (IBA)

45	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 08/2002
15	Tyrosine Kinase InhibitorsIBA 12/2021 - 08/2002
12	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021 - 07/2003
12	Pharmaceutical PreparationsIBA 01/2021 - 06/2003
10	Phosphotransferases (Kinase)IBA 03/2021 - 12/2003
10	TrabectedinIBA 01/2021 - 10/2008
9	Sunitinib (Sutent)FDA Link 01/2018 - 12/2003
7	DNA (Deoxyribonucleic Acid)IBA 08/2017 - 05/2005
6	Dacarbazine (DIC)FDA LinkGeneric 12/2019 - 03/2016
6	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2011
5	avapritinibIBA 01/2022 - 01/2021
5	ripretinibIBA 12/2021 - 01/2020
5	regorafenibIBA 10/2021 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 03/2018 - 05/2005
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2017 - 08/2002
4	Tyrosine (L-Tyrosine)FDA Link 03/2021 - 04/2004
4	VaccinesIBA 07/2011 - 02/2005
3	Dasatinib (BMS 354825)FDA Link 01/2018 - 03/2016
3	AnthracyclinesIBA 01/2017 - 09/2009
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2015 - 10/2008
3	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2013 - 08/2005
3	Insulin-Like PeptidesIBA 01/2013 - 06/2008
3	Aurora Kinase AIBA 09/2012 - 02/2011
3	Platelet-Derived Growth Factor alpha ReceptorIBA 10/2008 - 05/2005
3	Growth Factor ReceptorsIBA 07/2008 - 01/2003
2	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 01/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 07/2008
2	EnzymesIBA 08/2017 - 11/2015
2	Alanine Transaminase (SGPT)IBA 05/2015 - 10/2008
2	AntibodiesIBA 09/2014 - 01/2003
2	Sorafenib (BAY 43-9006)FDA Link 08/2012 - 02/2012
2	Peptides (Polypeptides)IBA 07/2011 - 07/2010
2	nilotinib FDA Link 04/2011 - 09/2009
2	MLN8054IBA 04/2011 - 02/2011
2	Aurora KinasesIBA 02/2011 - 11/2009
2	AntigensIBA 07/2010 - 02/2005
2	Ifosfamide FDA LinkGeneric 03/2010 - 09/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2010 - 10/2008
2	mapatumumabIBA 09/2009 - 04/2007
2	TOR Serine-Threonine KinasesIBA 08/2007 - 12/2003
1	atezolizumabIBA 01/2022
1	ponatinibIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	selinexorIBA 01/2022
1	Circulating Tumor DNAIBA 12/2021
1	DesminIBA 10/2021
1	SynaptophysinIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	CAM 5.2 antigenIBA 10/2021
1	Tumor Biomarkers (Tumor Markers)IBA 09/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	Alkylating AgentsIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2020

Therapy/Procedure

47	Therapeutics 01/2022 - 08/2002
17	Drug Therapy (Chemotherapy) 12/2019 - 08/2002
7	Radiotherapy 12/2020 - 05/2006
2	Neoadjuvant Therapy 01/2021 - 07/2008
1	Duration of Therapy 11/2021
1	Immunotherapy 09/2021
1	Nephrectomy 12/2019